Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. S-3/A Offering Registration Statement
  2. S-3 Offering Registration Statement
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. S-3 Offering Registration Statement
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-3 Offering Registration Statement
  13. 424B5 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. 424B3 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. S-1 Offering Registration Statement
  19. 424B4 Offering Prospectus
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 2 · 29 filings